Title:
E-LIQUID
Document Type and Number:
WIPO Patent Application WO/2021/036121
Kind Code:
A1
Abstract:
An e-liquid, comprising naringenin, wherein the content of naringenin in the e-liquid is 0.09% to 10% the total weight of the e-liquid. After the e-liquid is atomized, the naringenin contained therein may be atomized together with the e-liquid and absorbed by a human body, thereby achieving anti-inflammatory, cough-relieving and phlegm-eliminating effects, and inhibiting oral and respiratory bacteria. Moreover, the taste of the e-liquid after atomization is made more comfortable and milder, the aroma of the cigarette is enriched, and the quality of smoking is improved.
Inventors:
XU JING (CN)
JIANG XINGTAO (CN)
XIONG ZANHUA (CN)
LI XINDUO (CN)
JIANG XINGTAO (CN)
XIONG ZANHUA (CN)
LI XINDUO (CN)
Application Number:
PCT/CN2019/127156
Publication Date:
March 04, 2021
Filing Date:
December 20, 2019
Export Citation:
Assignee:
SHENZHEN RELX TECH CO LTD (CN)
International Classes:
A24B15/16
Foreign References:
| CN103622154A | 2014-03-12 | |||
| CN105029689A | 2015-11-11 | |||
| CN110353298A | 2019-10-22 | |||
| CN103284317A | 2013-09-11 | |||
| CN104605484A | 2015-05-13 | |||
| JPH09121829A | 1997-05-13 |
Attorney, Agent or Firm:
LEE AND LI-LEAVEN IPR AGENCY LTD. (CN)
Download PDF:
Previous Patent: MOBILE COOLING LIQUID PURIFICATION AND REGENERATION DEVICE
Next Patent: ELECTRONIC CIGARETTE LIQUID
Next Patent: ELECTRONIC CIGARETTE LIQUID